Does Access Location Influence Outcome of Percutaneous Nephrolithotomy in Staghorn Stones?


Journal

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
ISSN: 1681-7168
Titre abrégé: J Coll Physicians Surg Pak
Pays: Pakistan
ID NLM: 9606447

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 11 06 2021
accepted: 26 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 14 9 2021
Statut: ppublish

Résumé

To assess the effect of lower and middle calyceal accesses on the outcomes of percutaneous nephrolithotomy (PCNL) in staghorn stones. Observational study. Department of Urology, University of Health Sciences, Izmir Bozyaka Training and Research Hospital, Turkey, from April 2012 to January 2019. Patients who underwent PCNL for staghorn stones were retrospectively analysed. The patients were grouped as Group-1 (middle calyceal access) and Group-2 (lower calyceal access). Demographic and stone characteristics (size, density), perioperative and postoperative data, and stone-free rates were compared between these two groups. Postoperative detection of > 4 mm stones was defined as residual stones. There were 249 patients in the study; 108 in middle calyceal access group and 141 in lower calyceal access group. The mean stone burden was 765 (524-1322) and 777 (490-1445) mm2 in group-1 and group-2, respectively (p=0.876). The number of stone-free patients was 50 (46.3%) in middle calyceal access group and 93 (66.0%) in lower calyceal access group. The rate of stone-free status was significantly higher in lower calyceal access group (p=0.002). The overall complication rate was similar between the groups (p=0.132). The binary analysis showed that stone burden, and calyx of entry were predictive factors for success. Although the choice of the calyx to be entered does not affect the complication rate in staghorn stones, the stone-free rate is significantly higher in lower calyceal access. Key Words: Percutaneous nephrolithotomy, Staghorn stones, Clavien scoring system, Calyx, Access.

Identifiants

pubmed: 34500524
pii: 040579197
doi: 10.29271/jcpsp.2021.09.1075
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1075-1080

Auteurs

Serkan Yarimoglu (S)

Department of Urology, HSU Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.

Murat Sahan (M)

Department of Urology, HSU Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.

Salih Polat (S)

Department of Urology, Faculty of Medicine, Amasya Unisersity, Amasya, Turkey.

Gurkan Cesur (G)

Department of Urology, HSU Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.

Omer Koras (O)

Department of Urology, Faculty of Medicine, Hatay University, Hatay, Turkey.

Tansu Degirmenci (T)

Department of Urology, HSU Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH